We assessed the relationship between the severity of coronary artery disease assessed by SYNTAX score (SS) and neutrophil to lymphocyte ratio (N:L ratio) in patients with ST elevation myocardial infarction (STEMI). In total, 840 patients with STEMI in whom primary percutaneous coronary intervention was performed were prospectively included (622 male, 218 female; mean age 58.6 ± 12.4 years). Total and differential leukocyte counts and other biochemical markers were measured at admission. Patients were categorized into tertiles on the basis of SS. The N:L ratio of SShigh group was higher compared with SSlow and SSmid groups (P < .001 for all). Multivariate regression analysis showed that N:L ratio (β = .277, P < .001), ejection fraction (β = −.086, P = .012), age (β = .104, P = .004), and diabetes (β = .152, P < .001) were the independent predictors for SS in patients with STEMI.
RossR. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340(2):115–126.
2.
LibbyP.What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol. 2001;88(7B):3J–6J.
3.
GurmHSBhattDLLincoffAM. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart. 2003;89(10):1200–1204.
4.
GurmHSBhattDLGuptaREllisSGTopolEJLauerMS. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J. 2003;146(4):692–698.
5.
GillumRFMussolinoMEMadansJH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol. 2005;15(4):266–271.
6.
HorneBDAndersonJLJohnJM; Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk?J Am Coll Cardiol. 2005;45(10):1638–1643.
7.
PapaAEmdinMPassinoCMichelassiCBattagliaDCocciF. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta. 2008;395(1-2):27–31.
8.
NúñezJNúñezEBodíV. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101(6):747–752.
9.
SianosGMorelMAKappeteinAP. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–227.
10.
CapodannoDDi SalvoMECincottaGMianoMTamburinoCTamburinoC. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv. 2009;2(4):302–308.
11.
CapodannoDCapranzanoPDi SalvoME. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv. 2009;2(8):731–738.
12.
ValgimigliMSerruysPWTsuchidaK; ARTS II. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol. 2007;99(8):1072–1081.
13.
WykrzykowskaJJGargSGirasisC. Value of the SYNTAX score (SX) for risk assessment in the “all-comers” population of the randomized multicenter LEADERS Trial. J Am Coll Cardiol. 2010;56(4):272–277.
14.
GirasisCGargSRäberL. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J. 2011;32(24):3115–3127.
15.
. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21(18):1502–1513.
16.
SchillerNBShahPMCrawfordM. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358–367.
17.
SerruysPWOnumaYGargS. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009;5(1):50–56.
18.
HoffmanMBlumABaruchRKaplanEBenjaminM. Leukocytes and coronary heart disease. Atherosclerosis. 2004;172(1):1–6.
19.
OttINeumannFJGawazMSchmittMSchömigA. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation. 1996;94(6):1239–1246.
20.
MaxwellSRJLipGYH. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol. 1997;58(2):95–117.
21.
FurmanMIBeckerRCYarzebskiJSavegeauJGoreJMGoldbergRJ. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol. 1996;78(8):945–948.
22.
KirtaneAJBuiAMurphySABarronHVGibsonCM. Association of peripheral neutrophilia with adverse angiographic outcomes in ST elevation myocardial infarction. Am J Cardiol. 2004;93(5):532–536.
23.
AvanzasPQuilesJLopez de SaE. Neutrophil count and infarct size in patients with acute myocardial infarction. Int J Cardiol. 2004;97(1):155–156.
24.
FiarresgaAJFerreiraRCFelicianoJ. Prognostic value of neutrophil response in the era of acute myocardial infarction mechanical reperfusion. Rev Port Cardiol. 2004;23(11):1387–1396.
25.
ErikssonEEXieXWerrJThorenPLindbomL. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J. 2001;15(7):1149–1157.
26.
NarukoTUedaMHazeK. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106(23):2894–2900.
27.
SarmaJLaanCAAlamSJhaAFoxKADransfieldI. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation. 2002;105(18):2166–2171.
28.
BarronHCannonCMurphySBraunwaldEGibsonCM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation. 2000;102(19):2329–2334.
29.
PelizzonGDixonSStoneG. Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial). Am J Cardiol. 2003;91(6):729–731.
30.
SiminiakTFloresNSheridanD. Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury. Eur Heart J. 1995;16(2):160–170.
31.
DuclouxDChallierBSaasPTiberghienPChalopinJM. CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J Am Soc Nephrol. 2003;14(3):767–772.
32.
OnsrudMThorsbyE.Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol. 1981;13(6):573–579.
33.
ThomsonSPGibbonsRJSmarsPA. Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Ann Intern Med. 1995;122(5):335–341.
34.
SabatineMSMorrowDACannonCP. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. A TACTICS-TIMI 18 Substudy. J Am Coll Cardiol. 2002;40(10):1761–1768.
35.
AvramakisGPapadimitrakiEPapakonstandinouD. Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina. Platelets. 2007;18(1):16–23.
36.
BickelCRupprechtHJBlankenbergS. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol. 2002;89(1):12–17.
37.
LazzeriCValenteSChiostriMSoriABernardoPGensiniGF. Gensini uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol. 2010;138(2):206–209.
38.
GurMYilmazRDemirbagRAksoyN. Relation of serum uric acid levels with the presence and severity of angiographic coronary artery disease. Angiology. 2008;59(2):166–171.
39.
WheelerJGJuzwishinKDEiriksdottirGGudnasonVDaneshJ. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med. 2005;2(3):e76.
40.
DuranMKalayNAkpekM. High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome [published online November 21]. Angiology. 2011. doi: 10.1177/0003319711426868.
